In accordance with Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018, for the Quarter ended December 31, 2022 based on the certificate received from Beetal Financial & Computer Services (RTA) dated 05/01/2023, which is enclosed, Titan Biotech has forwarded the same for the reference.
The above information is a part of company’s filings submitted to BSE.